After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science to 2025 strategy has been finalized. Here, we highlight the core recommendations that stakeholders deem most significant to advance evidence generation.

中文翻译：

---

欧盟监管科学的未来：欧洲药品管理局的策略。

经过与利益相关者和欧盟监管合作伙伴的三年合作设计，欧洲药品管理局的《监管科学到2025年》战略已经完成。在这里，我们重点介绍了利益相关者认为对促进证据生成最重要的核心建议。